HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Mid-term natural course in Naples of chronic HBeAg positive infection caused by the HB-virus. Prospective study, preliminary to antiviral treatment].

Abstract
41 consecutively observed patients with chronic HB virus infection in replication phase (HBeAG positive) were followed up for an average period of 60 months with a view to evaluating the frequency of spontaneous HBeAg/anti-HBe seroconversion and the influence of the event on the clinical course of the liver disease. The 41 patients, of mean age 22 years, suffered from: 26 ECP, 7 ECA, 8 CIRR. 18 patients (41%) presented HBeAg/anti-HBe seroconversion with an annual percentage of 12%, all with stable normalisation of hepatic cytolysis tests. Factors related to HBeAg/anti-HBe seroconversion were: female sex, higher mean starting values of transaminase, positive history for EVA, absence of Virus Delta superinfection. The effectiveness of antiviral treatments will only be demonstrated when seroconversion (inhibition of viral replication) is produced much more frequently than that which occurs spontaneously. Candidates for current antiviral treatment are indicated.
AuthorsC Canestrini, L Amitrano, A Ascione, A De Lella, M De Luca, U Ferbo, E Riccio, T Gigliotti
JournalMinerva dietologica e gastroenterologica (Minerva Dietol Gastroenterol) 1989 Apr-Jun Vol. 35 Issue 2 Pg. 119-22 ISSN: 0391-1993 [Print] Italy
Vernacular TitleL'andamento naturale a medio termine a Napoli della infezione cronica da HB-virus HBeAg positiva. Studio prospettivo, preliminare al trattamento antivirale.
PMID2761751 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Hepatitis B Antibodies
  • Hepatitis B e Antigens
Topics
  • Adolescent
  • Adult
  • Child
  • Chronic Disease
  • Female
  • Follow-Up Studies
  • Hepatitis B (immunology)
  • Hepatitis B Antibodies (immunology)
  • Hepatitis B e Antigens (immunology)
  • Humans
  • Italy
  • Male
  • Prospective Studies
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: